7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TQ0219 | MK-8033 | c-Met/HGFR | |
MK-8033 is a new and selective dual ATP competitive c-Met/Ron inhibitor (IC50: 1 nM Wt c-Met). | |||
T10021 | 1-Methylxanthine | Endogenous Metabolite | |
1-Methylxanthine is a caffeine derivative. 1-Methylxanthine is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP). 1-Methylxanthine enhances the radiosensitivity of tumor cells. | |||
T61189 | E7016 | GPI 21016 | PARP |
E7016 (GPI 21016) is an orally available PARP inhibitor. E7016 inhibits of DNA repair. E7016 can enhance tumor cell radiosensitivity in vitro and in vivo. | |||
T40069 | SENP1-IN-2 | SENP1-IN-2 | |
SENP1-IN-2, a distinct inhibitor of the deSUMOylation protease 1 (SENP1), is designed to enhance tumor radiosensitivity. | |||
T40066 | SENP1-IN-3 | SENP1-IN-3 | |
SENP1-IN-3 is a distinct inhibitor of the deSUMOylation protease 1 (SENP1), designed to enhance tumor radiosensitivity. | |||
T40068 | SENP1-IN-1 | SENP1-IN-1 | |
SENP1-IN-1 is a distinct inhibitor of the deSUMOylation protease 1 (SENP1), designed to enhance tumor radiosensitivity. | |||
T40067 | SENP1-IN-4 | SENP1-IN-4 | |
SENP1-IN-4, a distinct inhibitor of the deSUMOylation protease 1 (SENP1), is designed to enhance tumor radiosensitivity. |